|
楼主 |
发表于 25-1-2021 05:18 PM
|
显示全部楼层
The worldwide COVID-19 global pandemic has impacted the global economy adversely,across all industries including healthcare. The enforcement of Movement Control Order(“MCO”) on 18 March 2020 has resulted in a reduction of patient volumes due to patientsopting to postpone non-urgent and non-essential treatment and defer visits to hospitals andhealthcare facilities. This is evidenced by the decrease in patient numbers and bedoccupancy rate (“BOR”) especially in April and May 2020 of 25% and 32% respectively.However, upon implementation of the Recovery Movement Control Order (“RMCO”) whichcommenced on 10 June 2020, the Group saw an improvement in occupancy levels. Thiswas evidenced by the increase in average monthly BOR to an average of 51% in the currentquarter.The period post MCO and RMCO has seen a gradual improvement of our business activities,however, this increase is yet to surpass our performance in the same period in 2019. For the quarter ended 30 September 2020, the Group revenue of RM850.7 million is 7% loweras compared to RM919.1 million in the same quarter in 2019. The average BOR for threemonths period ended 30 September 2020 was recorded at 51%, a decrease from 73% forthe same period in 2019. Patient visits during this period was recorded at 736,265 patients,an 11% decrease from 827,736 patients in 2019. During the quarter, despite the reductionin the hospital revenue, the laboratory revenue from Lablink recorded an increase by 17%,which has soften the impact total revenue drop for the Group
英文。。。
|
|